Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Brain Cancer treatment details. Alternative. University of Lausanne, Lausanne, Switzerland

Survival: 6.6 months
Toxicity Grade: 4
Treatments: Alternative
Country: Switzerland
City/State/Province: Lausanne
Hospital: University of Lausanne
Journal: Link
Date: 9/2012

This phase 3 study involved 120 previously treated patients with recurrent glioblastoma. The median patient age was 54 years and 77% were male.

Patients were treated with an alternative therapy called NovoTTF-100A, which is a portable device that emits low intensity electric fields (tumor treatment fields) to physically interfere with the growth of cancer cells.

The most severe adverse effects were of grade 4 and included grade 3-4 nervous system disorders. Grade 1-2 contact dermatitis (skin irritation) was also reported.

The median overall survival was 6.6 months.

Some of the authors are employed by or receive funding from Novocure (makers of NovoTTF-100A) and other pharmaceutical companies.

Correspondence: Dr. Roger Stupp; email:

E-mail to a Friend Email Physician More Information